Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Bimodal liquid biopsy for cancer immunotherapy based on peptide engineering and nanoscale analysis

Biosensors and Bioelectronics(2022)10.1016/j.bios.2022.114445Source: DataRank Database

Bimodal liquid biopsy for cancer immunotherapy based on peptide engineering and nanoscale analysis is a research paper published in Biosensors and Bioelectronics (2022). On theSindex it has a DataRank of 0. It has been cited 34 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

34 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 2.56)OA: closedTopics (42)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (20)

Woo‐Jin Jeong ORCID,Roya Jafari,Luke J. Kubiatowicz ORCID,Ashita Nair,Michael J. Poellmann ORCID

Live enrichment

PubMed:35679646 OpenAlex:https://openalex.org/W4282004895

National Science Foundation

Grant: DMR-1808251

National Institutes of Health

Grant: 1R01AR069541

National Institute of Biomedical Imaging and Bioengineering

Grant: 1R21EB022374

National Institute of Biomedical Imaging and Bioengineering

Grant: P50-DE026787

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Dr. Ralph and Marian Falk Medical Research Trust

FWCI

2.56

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

closedLicense: http://www.elsevier.com/open-access/userlicense/1.0/

publisherhttps://api.elsevier.com/content/article/PII:S0956566322004857?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0956566322004857?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.bios.2022.114445

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35679646

Fields of Study

Immunotherapy and Immune ResponsesMonoclonal and Polyclonal Antibodies ResearchExtracellular vesicles in diseaseB7-H1 AntigenBiomarkers, TumorBiosensing TechniquesCarcinoma, Non-Small-Cell LungHumansImmunotherapyLiquid BiopsyLung NeoplasmsPeptides

MeSH Terms

Liquid BiopsyCarcinoma, Non-Small-Cell LungHumansImmunotherapyLung NeoplasmsPeptidesBiomarkers, TumorBiosensing TechniquesB7-H1 Antigen

Keywords

MicrovesiclesPeptideImmunotherapyBiomarkerExosomeLiquid biopsyCancer researchCirculating tumor cellCancer immunotherapyChemistryCancerMedicineInternal medicineBiochemistryMetastasisGenemicroRNAExosomesCirculating Tumor CellsPeptide EngineeringBimodal Liquid Biopsy

Sustainable Development Goals

SDG 0: Good health and well-being

Bimodal liquid biopsy for cancer immunotherapy based on peptide engineering and nanoscale analysis

FAIR Checklist

Authors (20)

Funding (6 grants)

Impact

Open Access

Topics